The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.
The Japan Times says regulations are needed to oversee human genome-editing research.
Japan needs to catch up on its gene-editing research efforts, the Japan News writes.
Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.
The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.
American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.
A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.
Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.
In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.